Jian Tian Selected Research

Heart Failure

1/2022	Assessment of causal direction between thyroid function and cardiometabolic health: a Mendelian randomization study.
11/2019	Implications of N-terminal pro-B-type natriuretic peptide in patients with three-vessel disease.
2/2019	Efficacy and safety of levothyroxine (L-T4) replacement on the exercise capability in chronic systolic heart failure patients with subclinical hypothyroidism: Study protocol for a multi-center, open label, randomized, parallel group trial (ThyroHeart-CHF).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jian Tian Research Topics

Disease

11	Neoplasms (Cancer) 02/2022 - 11/2013
9	Osteoarthritis 01/2022 - 01/2013
4	Fibrosis (Cirrhosis) 01/2020 - 01/2010
4	Knee Osteoarthritis 11/2016 - 01/2013
3	Heart Failure 01/2022 - 02/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2016
3	Myocardial Infarction 01/2022 - 07/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2017
3	Acute Coronary Syndrome 01/2022 - 01/2020
3	Osteoporosis 04/2021 - 06/2011
3	Thrombosis (Thrombus) 01/2020 - 07/2018
3	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 10/2014
3	Breast Neoplasms (Breast Cancer) 07/2019 - 01/2016
3	Bone Resorption 06/2012 - 06/2011
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2013
2	Stroke (Strokes) 01/2022 - 04/2016
2	Hypertension (High Blood Pressure) 01/2022 - 01/2020
2	Death (Near-Death Experience) 01/2022 - 11/2019
2	Coronary Disease (Coronary Heart Disease) 07/2020 - 06/2018
2	Obesity 01/2020 - 01/2013
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
2	Carcinogenesis 01/2020 - 10/2014
2	Inflammation (Inflammations) 01/2020 - 01/2013
2	Hyperuricemia 05/2019 - 02/2017
2	Prostatic Neoplasms (Prostate Cancer) 06/2014 - 04/2005
2	Pathologic Processes 02/2004 - 04/2003
1	Essential Hypertension 01/2022
1	Pulmonary Heart Disease (Cor Pulmonale) 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Acute Disease 01/2022
1	Atrial Fibrillation 04/2021
1	Tetralogy of Fallot (Fallot Tetralogy) 01/2021
1	Prediabetic State (Prediabetes) 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Infectious Arthritis (Septic Arthritis) 11/2020
1	Intracranial Aneurysm (Cerebral Aneurysm) 07/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Diabetes Mellitus 01/2020
1	ST Elevation Myocardial Infarction 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Angina Pectoris 01/2020
1	Psoriatic Arthritis 01/2020
1	Overweight 01/2020
1	Atherosclerosis 01/2020
1	Chondroblastoma 08/2019
1	Systolic Heart Failure 02/2019

Drug/Important Bio-Agent (IBA)

6	OsteopontinIBA 08/2020 - 01/2013
3	Pharmaceutical PreparationsIBA 02/2022 - 01/2016
3	LipidsIBA 04/2021 - 02/2019
3	CateninsIBA 01/2020 - 10/2014
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
3	SmokeIBA 06/2012 - 06/2011
2	Metal-Organic FrameworksIBA 02/2022 - 04/2021
2	Therapeutic UsesIBA 02/2022 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 02/2017
2	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2014
2	pro-brain natriuretic peptide (1-76)IBA 11/2019 - 02/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 06/2014
2	Messenger RNA (mRNA)IBA 05/2015 - 01/2013
2	CollagenIBA 01/2013 - 07/2009
1	PolymersIBA 02/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022
1	Cisplatin (Platino)FDA LinkGeneric 02/2022
1	1- ethynyl- 4- hydroperoxy- 1,2,3,4- tetrahydro- 1- naphtholIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	HydrogelsIBA 01/2022
1	Biopolymers (Biopolymer)IBA 01/2022
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	CypateIBA 04/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2021
1	PorphyrinsIBA 04/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2021
1	BilirubinIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Glycogen Synthase (Synthase I)IBA 01/2020
1	Circular RNAIBA 01/2020
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2020
1	Insulin Glargine (Lantus)FDA Link 01/2020
1	omega-Chloroacetophenone (Mace)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2019
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2019
1	CalciumIBA 05/2019

Therapy/Procedure

8	Therapeutics 02/2022 - 01/2016
4	Percutaneous Coronary Intervention 01/2022 - 01/2017
4	Stents 01/2021 - 07/2018
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 06/2018
2	Conscious Sedation 01/2021 - 07/2020
2	Drug-Eluting Stents 01/2020 - 12/2018
1	Combination Drug Therapy (Combination Chemotherapy) 02/2022
1	Precision Medicine 01/2021
1	Conservative Treatment 01/2020
1	Curettage 08/2019
1	Bone Transplantation (Bone Grafting) 08/2019